scispace - formally typeset
S

Sandra K. Burchett

Researcher at Boston Children's Hospital

Publications -  112
Citations -  7872

Sandra K. Burchett is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Viral load & Postpartum period. The author has an hindex of 45, co-authored 108 publications receiving 7498 citations. Previous affiliations of Sandra K. Burchett include University of Massachusetts Medical School & University of Alabama at Birmingham.

Papers
More filters
Journal ArticleDOI

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission

TL;DR: Neither higher HIV-1 RNA levels early in pregnancy nor higher levels late in pregnancy were associated with the timing of infection in the infants, and in pregnant women with HIV- 1 infection the level of plasma HIV-2 RNA predicts the risk but not the time of transmission of HIV-3 to their infants.
Journal ArticleDOI

Evolution and transmission of stable CTL escape mutations in HIV infection

TL;DR: Investigation of mother–child transmission in the setting of HLA-B27 expression suggests that CTL escape mutations in epitopes associated with suppression of viraemia will accumulate as the epidemic progresses, and therefore have important implications for vaccine design.
Journal ArticleDOI

Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor

TL;DR: Pregnant women in early labor who were without symptoms or signs of genital HSV infection were prospectively obtained HSV cultures from the cervix and external genitalia to define the risk factors associated with neonatal acquisition of herpes simplex virus (HSV) infection.
Journal ArticleDOI

Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

TL;DR: With HSV infection limited to the skin, eyes, or mouth, the presence of three or more recurrences of vesicles was associated with an increased risk of neurologic impairment as compared with two or fewer recurrence.
Journal ArticleDOI

A Controlled Trial Comparing Vidarabine with Acyclovir in Neonatal Herpes Simplex Virus Infection

TL;DR: In this article, a controlled trial comparing vidarabine with acyclovir for the treatment of neonatal HSV infection was conducted, where infants less than one month of age with virologically confirmed infection were randomly and blindly assigned to receive either intravenous vidaramabine (30 mg per kilogram of body weight per day; n = 95) or acalovir (30mg per kg per day, n = 107) for 10 days.